VC
Vivo Capital Portfolio holdings
AUM
$977M
This Quarter Return
+54.39%
1 Year Return
+209.68%
3 Year Return
+1,480.07%
5 Year Return
+2,591.98%
10 Year Return
–
AUM
$2.24B
AUM Growth
+$2.24B
(+30%)
Cap. Flow
-$59.8M
Cap. Flow
% of AUM
-2.67%
Top 10 Holdings %
Top 10 Hldgs %
66.48%
Holding
69
New
5
Increased
8
Reduced
20
Closed
10
Top Buys
| 1 |
Tarsus Pharmaceuticals
TARS
|
$134M |
| 2 |
Aligos Therapeutics
ALGS
|
$98.1M |
| 3 |
Olema Pharmaceuticals
OLMA
|
$59.6M |
| 4 |
Curis
CRIS
|
$11.5M |
| 5 |
10x Genomics
TXG
|
$8.35M |
Top Sells
| 1 |
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
|
$62M |
| 2 |
Immunovant
IMVT
|
$32.1M |
| 3 |
Rocket Pharmaceuticals
RCKT
|
$30.2M |
| 4 |
Arrowhead Research
ARWR
|
$28.5M |
| 5 |
Codexis
CDXS
|
$23.8M |
Sector Composition
| 1 | Healthcare | 90.89% |
| 2 | Financials | 5.49% |
| 3 | Materials | 3.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
ALX Oncology
ALXO
$62.7M
| $364M | 16.23% | 4,220,048 | – | – |
|
2
Ascendis Pharma
ASND
$11.8B
| $300M | 13.38% | 1,797,745 | – | – |
|
3
Harmony Biosciences
HRMY
$2.12B
| $164M | 7.31% | 4,534,341 | – | – |
|
|
4
Tarsus Pharmaceuticals
TARS
$2.47B
| $134M | 5.99% | +3,245,035 | New | +$134M |
|
|
NFH
5
DELISTED
New Frontier Health Corporation Ordinary Shares
NFH
| $123M | 5.49% | 14,300,000 | – | – |
|
|
6
Aligos Therapeutics
ALGS
$73.3M
| $98.1M | 4.38% | +3,547,030 | New | +$98.1M |
|
|
GTH
7
DELISTED
Genetron Holdings Limited ADS
GTH
| $88.8M | 3.96% | 6,339,860 | – | – |
|
|
AMRS
8
DELISTED
Amyris Inc.
AMRS
| $81.3M | 3.63% | 13,161,847 +2,933 | +0% | +$18.1K |
|
9
Legend Biotech
LEGN
$6.41B
| $77.6M | 3.46% | 2,755,007 -575,262 | -17% | -$16.2M |
|
|
10
Olema Pharmaceuticals
OLMA
$375M
| $59.6M | 2.66% | +1,238,575 | New | +$59.6M |
|
|
ISEE
11
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $41.2M | 1.84% | 5,966,527 | – | – |
|
|
SVA
12
DELISTED
Sinovac Biotech, Ltd
SVA
| $38.2M | 1.7% | 5,900,000 | – | – |
|
13
Passage Bio
PASG
$22.7M
| $38M | 1.7% | 1,487,038 -704,415 | -32% | -$18M |
|
14
Crinetics Pharmaceuticals
CRNX
$2.92B
| $33M | 1.47% | 2,335,889 +72,119 | +3% | +$1.02M |
|
15
Nkarta
NKTX
$151M
| $31.5M | 1.41% | 512,225 | – | – |
|
16
KalVista Pharmaceuticals
KALV
$678M
| $30.7M | 1.37% | 1,618,296 +141,500 | +10% | +$2.69M |
|
|
SRRA
17
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $30.7M | 1.37% | 1,917,074 | – | – |
|
18
Arcutis Biotherapeutics
ARQT
$1.86B
| $24.4M | 1.09% | 867,170 -246,095 | -22% | -$6.92M |
|
|
KDMN
19
DELISTED
Kadmon Holdings, Inc.
KDMN
| $24.1M | 1.08% | 5,817,459 +526,123 | +10% | +$2.18M |
|
20
Zai Lab
ZLAB
$3.68B
| $23.7M | 1.06% | 175,000 +52,893 | +43% | +$7.16M |
|
|
AVDL
21
Avadel Pharmaceuticals
AVDL
$1.43B
| $23.6M | 1.05% | 3,526,093 | – | – |
|
22
Celldex Therapeutics
CLDX
$1.47B
| $22.6M | 1.01% | 1,291,875 -430,625 | -25% | -$7.54M |
|
23
ESSA Pharma
EPIX
$11.4M
| $22.6M | 1.01% | 1,893,907 +377,042 | +25% | +$4.5M |
|
|
EIGR
24
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $22M | 0.98% | 1,791,257 | – | – |
|
|
VRNA
25
Verona Pharma
VRNA
$9.16B
| $21.3M | 0.95% | 3,048,507 | – | – |
|